Seres Therapeutics Inc (MCRB)
1.03
-0.04
(-3.74%)
USD |
NASDAQ |
May 02, 10:43
Seres Therapeutics Debt to Equity Ratio: -2.264 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | -2.264 |
September 30, 2023 | -6.688 |
June 30, 2023 | 4.455 |
March 31, 2023 | -1.070 |
December 31, 2022 | 4.734 |
September 30, 2022 | 0.7525 |
June 30, 2022 | 2.196 |
March 31, 2022 | 0.623 |
December 31, 2021 | 0.1874 |
September 30, 2021 | 0.1449 |
June 30, 2021 | 0.2507 |
March 31, 2021 | 0.1754 |
December 31, 2020 | 0.1436 |
September 30, 2020 | 0.1328 |
June 30, 2020 | -0.3792 |
March 31, 2020 | -0.4015 |
Date | Value |
---|---|
December 31, 2019 | -0.5101 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.688
Minimum
Sep 2023
4.734
Maximum
Dec 2022
0.1307
Average
0.1436
Median
Dec 2020
Debt to Equity Ratio Benchmarks
Integra Lifesciences Holdings Corp | 0.9444 |
Nuwellis Inc | 0.00 |
Axogen Inc | 0.4871 |
Axsome Therapeutics Inc | 0.9324 |
908 Devices Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 358.60M |
Total Liabilities (Quarterly) | 403.46M |
Shareholders Equity (Quarterly) | -44.86M |
Current Ratio | 1.778 |
Net Debt Paydown Yield | -5.36% |